US Patent Issued to Sumitomo Pharma on Oct. 20 for "Medicament for treating cancer comprising optically active azabicyclo ring derivative" (Japanese, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,141, issued on Oct. 20, was assigned to Sumitomo Pharma Co. Ltd. (Osaka, Japan).

"Medicament for treating cancer comprising optically active azabicyclo ring derivative" was invented by Ken Eguchi (Osaka, Japan), Akinobu Watanabe (Chuo-ku, Japan), Taeko Kusuda (Osaka, Japan), Mami Inoue (Osaka, Japan), Takafumi Shimizu (Osaka, Japan), Mariko Matsubara (Chuo-ku, Japan), Takahiro Kuwaki (Chuo-ku, Japan), Matthew Hitron (Marlborough, Mass.), Hongliang Cai (Marlborough, Mass.), Bo Xu (Marlborough, Mass.), Emily Brooks (Marlborough, Mass.), Curtis Allred (Marlborough, Mass.) and Vishnu Peddagali (Marlborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Of...